Literature DB >> 22895074

The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer.

Alexandra Giatromanolaki1, Michael I Koukourakis, Anastasios Koutsopoulos, Savvas Mendrinos, Efthimios Sivridis.   

Abstract

Tumor-associated stroma (TAS) is not simply a supporting element for cancer cells, but plays an important role in tumor growth, invasion and metastasis. Changes on the level of stromal constituents, such as loss of Caveolin-1 and increased thymidine phosphorylase (TP) expression, have been associated with tumor aggressiveness. The mutual cooperation between stromal fibroblasts and cancer cells is another distinguishing feature, which has recently emerged. In this investigation, both the loss of Caveolin-1 and the increased TP expression in the prostatic TAS was associated with high Gleason score (p = 0.0002 and 0.003, respectively); the two proteins were acting both independently and synergistically. In addition, TP was significantly associated with high stromal Ki-67 (MIB1) proliferation index (p = 0.03). Analysis of the metabolic interactions between stromal and epithelial elements showed that, while prostatic cancer cells express principally (> 91%) lactate dehydrogenase-5 (LDH-5) (anaerobic metabolism), the tumor-associated fibroblasts/myofibroblasts (TAFs) express largely (67.8%) LDH-1 (aerobic metabolism)-the terms TAFs and TAS are used interchangeably. These two isoenzyme pathways act complementary; the LDH-5 pathway converts pyruvate to lactate, whereas the LDH-1 enzyme system utilizes the secreted metabolite lactate to produce pyruvate, essential for continuous energy supply to tumor cells. Monocarboxylate transporter-1 (MCT-1)-the main facilitator of lactate uptake in tumor cells, was expressed exclusively in prostate cancer cells and related directly to LDH-5 overexpression. These findings support and extend our previous studies on energy recycling between the aerobic stroma and the anaerobic cancer cells within the framework of Warburg effect.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895074      PMCID: PMC3493436          DOI: 10.4161/cbt.21785

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  23 in total

1.  Thymidine phosphorylase expression in endometrial carcinomas.

Authors:  E Sivridis; A Giatromanolaki; M I Koukourakis; R Bicknell; A L Harris; K C Gatter
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis.

Authors:  Jacky G Goetz; Susana Minguet; Inmaculada Navarro-Lérida; Juan José Lazcano; Rafael Samaniego; Enrique Calvo; Marta Tello; Teresa Osteso-Ibáñez; Teijo Pellinen; Asier Echarri; Ana Cerezo; Andres J P Klein-Szanto; Ricardo Garcia; Patricia J Keely; Paloma Sánchez-Mateos; Edna Cukierman; Miguel A Del Pozo
Journal:  Cell       Date:  2011-07-08       Impact factor: 41.582

3.  Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas.

Authors:  Efthimios Sivridis; Alexandra Giatromanolaki; Panagiotis Anastasiadis; Loukas Georgiou; Kevin C Gatter; Adrian L Harris; Roy Bicknell; Michael I Koukourakis
Journal:  J Pathol       Date:  2002-04       Impact factor: 7.996

4.  Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment.

Authors:  Yanique I Rattigan; Brijesh B Patel; Ellen Ackerstaff; George Sukenick; Jason A Koutcher; John W Glod; Debabrata Banerjee
Journal:  Exp Cell Res       Date:  2011-12-08       Impact factor: 3.905

5.  Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.

Authors:  Michael I Koukourakis; Alexandra Giatromanolaki; Rolf A Brekken; Efthimios Sivridis; Kevin C Gatter; Adrian L Harris; E Helene Sage
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

6.  "Stromatogenesis" and tumor progression.

Authors:  Efthimios Sivridis; Alexandra Giatromanolaki; Michael I Koukourakis
Journal:  Int J Surg Pathol       Date:  2004-01       Impact factor: 1.271

Review 7.  Role of the stromal microenvironment in carcinogenesis of the prostate.

Authors:  Gerald R Cunha; Simon W Hayward; Y Z Wang; William A Ricke
Journal:  Int J Cancer       Date:  2003-10-20       Impact factor: 7.396

Review 8.  The pathology of tumor stromatogenesis.

Authors:  Alexandra Giatromanolaki; Efthimios Sivridis; Michael I Koukourakis
Journal:  Cancer Biol Ther       Date:  2007-05-30       Impact factor: 4.742

9.  Metabolic compartments in tumor tissue: implications for therapy.

Authors:  Adrian L Harris
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

10.  Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis.

Authors:  E Sivridis; A Giatromanolaki; I Papadopoulos; K C Gatter; A L Harris; M I Koukourakis
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640

View more
  27 in total

1.  Estrogen receptor β exon 3-deleted mouse: The importance of non-ERE pathways in ERβ signaling.

Authors:  Laure Maneix; Per Antonson; Patricia Humire; Sabrina Rochel-Maia; Jessica Castañeda; Yoko Omoto; Hyun-Jin Kim; Margaret Warner; Jan-Åke Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

2.  PPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth.

Authors:  Omran Abu Aboud; Dallas Donohoe; Scott Bultman; Mark Fitch; Tim Riiff; Marc Hellerstein; Robert H Weiss
Journal:  Am J Physiol Cell Physiol       Date:  2015-03-25       Impact factor: 4.249

3.  Metabolic cooperation between co-cultured lung cancer cells and lung fibroblasts.

Authors:  Michael I Koukourakis; Dimitra Kalamida; Achilleas G Mitrakas; Maria Liousia; Stamatia Pouliliou; Efthimios Sivridis; Alexandra Giatromanolaki
Journal:  Lab Invest       Date:  2017-08-28       Impact factor: 5.662

Review 4.  RANK-mediated signaling network and cancer metastasis.

Authors:  Gina Chia-Yi Chu; Leland W K Chung
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

Review 5.  Caveolae and signalling in cancer.

Authors:  Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Nat Rev Cancer       Date:  2015-04       Impact factor: 60.716

Review 6.  The biology of castration-resistant prostate cancer.

Authors:  Fei Lian; Nitya V Sharma; Josue D Moran; Carlos S Moreno
Journal:  Curr Probl Cancer       Date:  2014-11-25       Impact factor: 3.187

7.  Hereditary ovarian cancer and two-compartment tumor metabolism: epithelial loss of BRCA1 induces hydrogen peroxide production, driving oxidative stress and NFκB activation in the tumor stroma.

Authors:  Ubaldo E Martinez-Outschoorn; Renee M Balliet; Zhao Lin; Diana Whitaker-Menezes; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2012-10-09       Impact factor: 4.534

Review 8.  Caveola-forming proteins caveolin-1 and PTRF in prostate cancer.

Authors:  Zeyad D Nassar; Michelle M Hill; Robert G Parton; Marie-Odile Parat
Journal:  Nat Rev Urol       Date:  2013-08-13       Impact factor: 14.432

Review 9.  Potential impact of tissue molecular heterogeneity on ambient mass spectrometry profiles: a note of caution in choosing the right disease model.

Authors:  Lauren Katz; Michael Woolman; Alessandra Tata; Arash Zarrine-Afsar
Journal:  Anal Bioanal Chem       Date:  2020-11-27       Impact factor: 4.142

10.  MCTS1 promotes the development of lung adenocarcinoma by regulating E2F1 expression.

Authors:  Cun Gao; Rui Dong; Yongmeng Li; Jinghui Liang; Hui Tian
Journal:  Oncol Lett       Date:  2021-05-17       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.